Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2295065rdf:typepubmed:Citationlld:pubmed
pubmed-article:2295065lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:2295065lifeskim:mentionsumls-concept:C1366557lld:lifeskim
pubmed-article:2295065lifeskim:mentionsumls-concept:C1704256lld:lifeskim
pubmed-article:2295065lifeskim:mentionsumls-concept:C0699790lld:lifeskim
pubmed-article:2295065lifeskim:mentionsumls-concept:C0007589lld:lifeskim
pubmed-article:2295065lifeskim:mentionsumls-concept:C0062641lld:lifeskim
pubmed-article:2295065lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:2295065lifeskim:mentionsumls-concept:C1511938lld:lifeskim
pubmed-article:2295065pubmed:issue2lld:pubmed
pubmed-article:2295065pubmed:dateCreated1990-2-13lld:pubmed
pubmed-article:2295065pubmed:abstractTextThe differentiation agent hexamethylene bisacetamide (HMBA) increased expression of transforming growth factor beta 1 (TGF beta 1) mRNA in HT29 colon carcinoma cells. The increase was evident after 24 h and was maintained at levels 4-5-fold the control levels for at least 5-13 days. No increase in expression of TGF beta 2 or TGF alpha mRNA was observed. Both TGF beta 1 and HMBA induced loss of expression of a cell surface malignancy marker on HT29 cells, and both decreased cell growth in serum-free medium. Exogenously applied TGF beta 1 mimicked the growth-arresting effect of HMBA on three surgically resected moderately differentiated colon carcinomas in serum-free primary culture. Both TGF beta 1 and HMBA increased the tumor growth fraction in a second group of three more aggressive colon carcinomas, while neither agent had any measurable growth-modulating activity on two other colon carcinomas. The induction of TGF beta 1 mRNA by HMBA along with the parallel biological effects of HMBA and exogenously applied TGF beta 1 on resected carcinomas and on HT29 cells suggest that the effects of HMBA on colon carcinoma cells may be mediated in part by induction of TGF beta 1.lld:pubmed
pubmed-article:2295065pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2295065pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2295065pubmed:languageenglld:pubmed
pubmed-article:2295065pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2295065pubmed:citationSubsetIMlld:pubmed
pubmed-article:2295065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2295065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2295065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2295065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2295065pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2295065pubmed:statusMEDLINElld:pubmed
pubmed-article:2295065pubmed:monthJanlld:pubmed
pubmed-article:2295065pubmed:issn0008-5472lld:pubmed
pubmed-article:2295065pubmed:authorpubmed-author:RifkinJJlld:pubmed
pubmed-article:2295065pubmed:authorpubmed-author:FriedmanEElld:pubmed
pubmed-article:2295065pubmed:authorpubmed-author:CoffeyR JRJlld:pubmed
pubmed-article:2295065pubmed:authorpubmed-author:WinawerSSlld:pubmed
pubmed-article:2295065pubmed:authorpubmed-author:SchroyPPlld:pubmed
pubmed-article:2295065pubmed:issnTypePrintlld:pubmed
pubmed-article:2295065pubmed:day15lld:pubmed
pubmed-article:2295065pubmed:volume50lld:pubmed
pubmed-article:2295065pubmed:ownerNLMlld:pubmed
pubmed-article:2295065pubmed:authorsCompleteYlld:pubmed
pubmed-article:2295065pubmed:pagination261-5lld:pubmed
pubmed-article:2295065pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2295065pubmed:meshHeadingpubmed-meshheading:2295065-...lld:pubmed
pubmed-article:2295065pubmed:meshHeadingpubmed-meshheading:2295065-...lld:pubmed
pubmed-article:2295065pubmed:meshHeadingpubmed-meshheading:2295065-...lld:pubmed
pubmed-article:2295065pubmed:meshHeadingpubmed-meshheading:2295065-...lld:pubmed
pubmed-article:2295065pubmed:meshHeadingpubmed-meshheading:2295065-...lld:pubmed
pubmed-article:2295065pubmed:meshHeadingpubmed-meshheading:2295065-...lld:pubmed
pubmed-article:2295065pubmed:meshHeadingpubmed-meshheading:2295065-...lld:pubmed
pubmed-article:2295065pubmed:meshHeadingpubmed-meshheading:2295065-...lld:pubmed
pubmed-article:2295065pubmed:meshHeadingpubmed-meshheading:2295065-...lld:pubmed
pubmed-article:2295065pubmed:year1990lld:pubmed
pubmed-article:2295065pubmed:articleTitleRole of transforming growth factor beta 1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide.lld:pubmed
pubmed-article:2295065pubmed:affiliationDepartment of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.lld:pubmed
pubmed-article:2295065pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2295065pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2295065pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2295065lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2295065lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2295065lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2295065lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2295065lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2295065lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2295065lld:pubmed